drugset / Trial / NCT00314821
Ropinirole in the Treatment of Bipolar Depression
Phase 4
Completed
40 enrolled
Cambridge Health Alliance
Emory University · collabGlaxoSmithKline · collab
RandomizedCrossoverDouble-blindTreatment
Summary
To demonstrate efficacy and safety of Requip in in treating bipolar depression.
Timeline
- Start
- 2005-09
- Primary completion
- 2007-06-01
- Completion
- 2008-03-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ropinirole | Small molecule | — | — |